| answer text |
<p>The Department funds research via the National Institute for Health Research (NIHR).</p><p>
</p><p>The NIHR welcomes funding applications for research into a wide range of areas
but does not usually ring-fence funds for particular topics. Awards are made in open
competition on the basis of importance of topics to patients and heath and care services,
value for money, and scientific quality judged through peer review. The amount of
future NIHR funding in specific topic areas will depend on the quality and quantity
of research proposals submitted to NIHR for review. As such, NIHR does not hold projected
funding allocations specifically for research into medicines.</p><p> </p><p>Information
on individual projects funded by the NIHR can be found at:</p><p> </p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/"
target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p> </p><p>However,
NIHR does hold information on previous spend on the types of biomedical and health
related research that are funded by NIHR and other funders, classified using the Health
Research Classification System (HRCS). Whilst HRCS does not have a category that is
specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and
evaluation of pharmaceutical treatments and therapeutic interventions and can be used
to classify NIHR Programme Spend. It is possible that these codes may include some
evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research
Network (CRN) undertakes research which supports clinical trials into pharmaceutical
treatments and therapeutic interventions. CRN funding data can be calculated based
on the number of recruiting ' Clinical Trial of an Investigational Medicinal Product
(CTIMP) ' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research
spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three
years where complete data is available is set out below:</p><p> </p><table><tbody><tr><td><p>
</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR
Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN
spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p>
</p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research
which may also contribute to the development and evaluation of pharmaceutical treatments
and therapeutic interventions carried out across NIHR Infrastructure is not coded
by the HRCS scheme so cannot be wholly attributed to individual research topics.</p>
|
|
